https://www.biospace.com/alnylam-pharmaceuticals-studying-the-history-of-genzyme-corporation-eyes-drug-to-make-big-difference-for-rare-disease
Alnylam Pharmaceuticals Studying the History of Genzyme Corporation Eyes Drug to Make Big...
the history of
https://www.biospace.com/ksq-emerges-with-76-million-and-will-be-helmed-by-former-b-genzyme-b-ceo
KSQ Emerges With $76 Million and Will be Helmed by Former Genzyme CEO - BioSpace
https://www.biospace.com/genzyme-convenes-sixth-annual-gaucher-leadership-forum
Genzyme Convenes Sixth Annual Gaucher Leadership Forum - BioSpace
leadership forumgenzymesixthannualgaucher
https://www.biospace.com/genzyme-corporation-named-one-of-b-fortune-b-s-100-best-companies-to-work-for
Genzyme Corporation Named One Of FORTUNE's '100 Best Companies To Work For' - BioSpace
best companies to work for
https://www.justgiving.com/fundraising/sanofigenzyme2018
Sanofi Genzyme is fundraising for Parasol
Help Sanofi Genzyme raise money to support Parasol
sanofigenzymefundraisingparasol
https://www.biospace.com/genzyme-beats-expectations-jumps-12-percent
Genzyme Beats Expectations, Jumps 12% - BioSpace
genzymebeatsexpectationsjumps12
https://www.biospace.com/b-genzyme-pharmaceuticals-b-and-brookwood-pharmaceuticals-inc-enter-broad-collaboration-in-drug-delivery-with-an-initial-focus-on-peptide-deliver
Genzyme Pharmaceuticals And Brookwood Pharmaceuticals, Inc. Enter Broad Collaboration In Drug...
genzymepharmaceuticalsbrookwoodincenter
https://3dprint.com/tag/sanofi-genzyme/
Sanofi Genzyme Archives - 3DPrint.com | Additive Manufacturing Business
additive manufacturingsanofigenzymearchives3dprint
https://www.ftc.gov/news-events/news/speeches/genzyme-corporations-acquisition-ilex-oncology-inc
Genzyme Corporation's Acquisition of ILEX Oncology, Inc. | Federal Trade Commission
genzyme corporationacquisition
https://www.biospace.com/genzyme-corporation-s-head-of-rare-diseases-honored-by-the-b-genetic-disease-foundation-b
Genzyme Corporation's Head of Rare Diseases Honored by the Genetic Disease Foundation - BioSpace
https://www.biospace.com/genzyme-corporation-study-demonstrates-one-administration-of-synvisc-improves-osteoarthritis-pain
Genzyme Corporation Study Demonstrates One Administration Of Synvisc Improves Osteoarthritis Pain -...
genzyme corporationstudydemonstratesone
https://www.gevernova.com/software/customer-stories/genzyme-accelerates-data-collection-and-reporting
Genzyme Accelerates Data Collection and Reporting | GE Vernova
Discover how Genzyme speeds up data collection and production reports while increasing operational equipment availability.
data collection and reportinggenzymeacceleratesvernova
https://www.biospace.com/de-novo-pharmaceuticals-ltd-announces-drug-discovery-collaboration-with-genzyme-corporation
De Novo Pharmaceuticals Ltd. Announces Drug Discovery Collaboration With Genzyme Corporation -...
de novodrug discoverypharmaceuticalsltdannounces
https://www.fiercebiotech.com/biotech/genzyme-on-buyouts-thanks-but-no-thanks
Genzyme on buyouts: Thanks but no thanks | Fierce Biotech
Dec 6, 2007 - We're happy the way we are, thank you very much. That's what Genzyme CEO Henri Termeer (photo) has to say to rumors that the
genzymebuyoutsthanksfiercebiotech
https://www.biospace.com/genzyme-recognizes-international-rare-disease-day-with-global-education-and-fund-raising-events-announces-founding-partnership-of-give-rare
Genzyme Recognizes International Rare Disease Day With Global Education And Fund-Raising Events;...
rare disease day
https://www.epo.org/fr/boards-of-appeal/decisions/t111673eu1
T 1673/11 (Treatment of Pompe's disease/GENZYME) du 20.10.2015
pompe s disease
https://www.epo.org/de/boards-of-appeal/decisions/t221259eu1
T 1259/22 (Plerixafor to mobilise progenitor/stem cells/GENZYME) vom 24.01.2024
https://www.foxbusiness.com/video/3053540734001
Alnylam president on $700M Genzyme deal | Fox Business Video
Biotech game changer?
fox businessalnylampresidentgenzymedeal
https://www.foxbusiness.com/markets/sanofi-extends-18-5-billion-genzyme-offer-to-january-21
Sanofi Extends $18.5 Billion Genzyme Offer to January 21 | Fox Business
Sanofi-Aventis extended its snubbed $18.5 billion cash bid for the. biotech group by six weeks.
18 5
https://www.prweb.com/releases/gallus_biopharmaceuticals_enters_clinical_supply_agreement_with_genzyme_for_niemann_pick_type_b_disease/prweb10981911.htm
Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B...
St. Louis, Missouri (PRWEB) July 31, 2013 -- Gallus Biopharmaceuticals, LLC (Gallus) has signed a development and manufacturing supply agreement with...